SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-23-000525
Accepted
2023-03-07 00:15:14
Documents
1
Effectiveness Date
2023-03-06
Registration Form
POS AM
Reference AccNo

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 617
  Complete submission text file 9999999995-23-000525.txt   1856
Mailing Address 355 S. GRAND AVENUE, SUITE 1450 LOS ANGELES CA 90071
Business Address 355 S. GRAND AVENUE, SUITE 1450 LOS ANGELES CA 90071 (847) 562-4300
Clarus Therapeutics Holdings, Inc. (Filer) CIK: 0001817944 (see all company filings)

IRS No.: 851231852 | State of Incorp.: DE | Fiscal Year End: 1231
Type: EFFECT | Act: 33 | File No.: 333-264231 | Film No.: 23710923
SIC: 2836 Biological Products, (No Diagnostic Substances)